FIELD: medicine.
SUBSTANCE: invention is a DNA molecule encoding an enzyme having glucoamylase activity, possessing at least 80% sequence identity with glucoamylase from Trichoderma, possessing the sequence of SEQ ID NO: 4. The invention also refers to vectors and host cells with integrated DNA sequences, enzyme compositions and methods of use of glucoamylase in various applications.
EFFECT: expansion of arsenal of glucoamylases.
45 cl, 20 dwg, 10 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS FOR PRODUCING GLUCOSE SYRUPS | 2015 |
|
RU2706297C2 |
| GLUCOAMILASES AND METHODS OF THEIR USE | 2019 |
|
RU2802790C2 |
| SOLUBILIZED APIRASES, METHODS AND APPLICATIONS | 2019 |
|
RU2791992C2 |
| CHIMERIC ANTIGEN RECEPTORS TARGETED TO FC RECEPTOR-LIKE PROTEIN 5, AND THEIR USE | 2015 |
|
RU2779747C2 |
| ANTIBODIES TO PAC1 AND THEIR APPLICATION OPTIONS | 2019 |
|
RU2781553C2 |
| ANTIBODY FOR SPECIFIC BINDING TO N-TERMINAL DOMAIN OF LYSYL-TRNA SYNTHETASE EXPOSED ON EXTRACELLULAR MEMBRANE | 2019 |
|
RU2781304C1 |
| ANTIBODIES DIRECTED AGAINST Fc-RECEPTOR-LIKE PROTEIN 5 AND METHODS FOR THEIR APPLICATION | 2016 |
|
RU2774158C2 |
| ANTI-PD-L1 ANTIBODY FOR PD-L1 DETECTION | 2018 |
|
RU2758723C2 |
| COMPOSITIONS AND METHODS OF GENE EDITING | 2019 |
|
RU2804665C2 |
| RECOMBINANT PROTEINS WITH CCN DOMAINS AND FUSION PROTEINS | 2020 |
|
RU2825102C2 |
